Zymeworks Inc. (ZYME)
NASDAQ: ZYME · Real-Time Price · USD
23.90
+5.38 (29.05%)
At close: Nov 17, 2025, 4:00 PM EST
23.96
+0.06 (0.25%)
After-hours: Nov 17, 2025, 7:59 PM EST
Zymeworks Market Cap
Zymeworks has a market cap or net worth of $1.79 billion as of November 17, 2025. Its market cap has increased by 81.51% in one year.
Market Cap
1.79B
Enterprise Value
1.51B
1-Year Change
81.51%
Ranking
Category
Stock Price
$23.90
Market Cap Chart
Since April 28, 2017, Zymeworks's market cap has increased from $329.40M to $1.79B, an increase of 442.99%. That is a compound annual growth rate of 21.87%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Nov 14, 2025 | 1.39B | 37.45% |
| Dec 31, 2024 | 1.01B | 38.65% |
| Dec 29, 2023 | 727.30M | 46.87% |
| Dec 30, 2022 | 495.20M | -35.10% |
| Dec 31, 2021 | 763.00M | -64.77% |
| Dec 31, 2020 | 2.17B | 20.97% |
| Dec 31, 2019 | 1.79B | 281.53% |
| Dec 31, 2018 | 469.30M | 143.92% |
| Dec 29, 2017 | 192.40M | -41.59% |
| Apr 28, 2017 | 329.40M | - |
View and export this data all the way back to 2017. Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 918.02B |
| Johnson & Johnson | 472.05B |
| AbbVie | 410.67B |
| UnitedHealth Group | 291.55B |
| AstraZeneca | 276.16B |
| Novartis AG | 252.58B |
| Merck & Co. | 230.63B |
| Abbott Laboratories | 227.08B |